Development of Ptosis After Vitreo-retinal Surgery
Conditions
Keywords
ptosis, retina surgery, droopy eye lid
Brief summary
The purpose of this study to is to determine the incidence of post-operative ptosis in patients undergoing vitreoretinal surgery. An additional purpose is to identify pre-operative and intra-operative factors which correlate to the development of post-operative ptosis in vitreoretinal surgery cases.
Detailed description
This study will evaluate patients who will undergo vitreoretinal surgery at UCSF Medical Center and San Francisco General Hospital. After informed consent has been obtained, the measurement of eyelid parameters such as levator function, palpebral fissure height, upper eyelid crease height, MRD1 and MRD2 will be collected at pre-operative and post-operative follow up visits. External eye photographs taken at each visit will be evaluated by a masked reader who will calculate the eyelid parameters. Dermographic data and intraoperative factors such as operative time and type of procedure will be collected. For statistical analysis, Repeated ANOVA, Paired t-test, Wilcoxon signed rank test, Chi-square test and Pearson's correlation analysis will be calculated with SPSS software.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients who have vitreoretinal surgery from January 2013
Exclusion criteria
* Minors, younger than age 18. * Patients who have pre-existing ptosis at baseline in the operative eye. * Patients who are not able to cooperate with eyelid ptosis measurements
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Reduction of levator function | Baseline to 6 months | Difference between levator function at baseline and 6 months after surgery |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Operative time | At operation | Record of operative surgical time in each type of operation |
| Change of palpebral fissure height, MRD1 and MRD2 | Baseline to 6 months | Difference in palpebral fissure height, MRD1 and MRD2 between baseline and each post-operative visit. |
| Incidence of ptosis | baseline to 6 months | Incidence of clinically significant ptosis, defined as upper eyelid drooping of more than 2 mm. |
Countries
United States